Insulin Glargine Safety in Pregnancy: A transplacental transfer study

OBJECTIVE: Insulin glargine (Lantus) is an extended-action insulin analog with greater stability and duration of action than regular human insulin. The long duration of action and decreased incidence of hypoglycemia provide potential advantages for its use in pregnancy. However, the placental pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollex, Erika K., Feig, Denice S., Lubetsky, Angelika, Yip, Paul M., Koren, Gideon
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797979/
https://www.ncbi.nlm.nih.gov/pubmed/19808914
http://dx.doi.org/10.2337/dc09-1045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797979/
https://www.ncbi.nlm.nih.gov/pubmed/19808914
http://dx.doi.org/10.2337/dc09-1045

Ejemplares similares